PIPr Therapeutics, Inc. — Form D/A
PIPr Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2022-06-15. The offering totals $18.9M, of which $18.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-15
- Form: D/A
- Accession: 0001687466-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.9M
- Amount sold: $18.9M
- Investors: 7
- Date of first sale: 2020-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384210
Issuer
- Name: PIPr Therapeutics, Inc.
- CIK: 0001687466
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 280 S. MANGUM ST., DURHAM, NC, 27701
- Phone: 9193578326
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Bridget Ann Martell | Director | South San Francisco, CA |
| St. John Donnie McGrath | Director | New Haven, CT |
| Christy Ann Shaffer | Director | Chapel Hill, NC |
| E. Jonathan Soderstrom | Director | New Haven, CT |
| Holden Jonathan Thorp | Director | St. Louis, MO |
| Bridget Ann Martell | Executive Officer | South San Francisco, CA |
| Clay Thorp | Director | Durham, NC |
| Holden Thorp | Director | Durham, NC |
| Heather Madsen | Director | Durham, NC |
| Heather Madsen | Executive Officer | Durham, NC |
| Holden H Thorp | Director | St. Louis, MO |
| Jonathan H Soderstrom | Director | New Haven, CT |
| Christy H Shaffer | Director | Chapel Hill, NC |
| James H Rosen | Director | Chapel Hill, NC |
| James H Rosen | Executive Officer | Chapel Hill, NC |
| Donnie H McGrath | Director | New Haven, CT |
| Moncef H Slaoui | Director | King of Prussia, PA |
| Marian H Nakada | Director | New Brunswick, NJ |
| William Wiesler | Director | Durham, NC |
| William Wiesler | Executive Officer | Durham, NC |
Other filings by this issuer (5)
More